BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15933573)

  • 1. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.
    Husain E; Whitehead S; Castell A; Thomas EE; Speert DP
    Pediatr Infect Dis J; 2005 Jun; 24(6):563-6. PubMed ID: 15933573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillin resistance in viridans streptococcal bacteremia is related with high mortality.
    Docze A; Mraz M; Grey E; Bucko E; Korcova J; Svetlansky I; Sabo Z; Krcméry V
    Scand J Infect Dis; 2003; 35(11-12):916-7. PubMed ID: 14723386
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents.
    Smith A; Jackson MS; Kennedy H
    Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.
    Han XY; Kamana M; Rolston KV
    J Clin Microbiol; 2006 Jan; 44(1):160-5. PubMed ID: 16390964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to penicillin and erythromycin in viridans streptococcal bloodstream isolates from cancer and non-cancer patients within 10 years.
    Ondrusova A; Liskova A; Miklosko J; Babela R; Krcmery V
    Infect Control Hosp Epidemiol; 2004 May; 25(5):365-7. PubMed ID: 15188839
    [No Abstract]   [Full Text] [Related]  

  • 6. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
    Fujitani S; Rowlinson MC; George WL
    Clin Infect Dis; 2008 Apr; 46(7):1064-6. PubMed ID: 18444825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
    Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
    Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
    Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R; Hassall T; Morland B; Gray J
    Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes.
    Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
    Int J Antimicrob Agents; 2006 Oct; 28(4):292-6. PubMed ID: 16938436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin resistance in viridans streptococci bacteremia is clinically significant.
    Grey E; Mraz M; Docze A; Korcova J; Bucko E; Krcmery V
    Chemotherapy; 2007; 53(1):42-3. PubMed ID: 17202810
    [No Abstract]   [Full Text] [Related]  

  • 13. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
    Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
    Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
    Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
    Bruckner L; Gigliotti F
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
    Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
    J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
    Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
    J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.
    Lyytikäinen O; Rautio M; Carlson P; Anttila VJ; Vuento R; Sarkkinen H; Kostiala A; Väisänen ML; Kanervo A; Ruutu P
    J Antimicrob Chemother; 2004 Apr; 53(4):631-4. PubMed ID: 15014065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.